Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing

Results in Immunology

Volumn 3, Issue , 2013, Pages 114-121

  Hair, Pamela S ^a   Foley, Caitlin K ^a   Krishna, Neel K ^a   Nyalwidhe, Julius O ^a   Geoghegan, Joan A ^b   Foster, Timothy J ^b   Cunnion, Kenji M ^a,c,d  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c Children's Specialty Group   (United States)

^d CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

Author keywords

C4BP; Complement; Opsonophagocytosis; SdrE; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; BONE SIALOPROTEIN BINDING PROTEIN; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT FACTOR H; MEMBRANE PROTEIN; PROTEIN SDRE; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; CLONE; COMPLEMENT INHIBITION; CONTROLLED STUDY; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; IMMUNE EVASION; LACTOCOCCUS LACTIS; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPSONIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS;

EID: 84888351130     PISSN: None     EISSN: 22112839     Source Type: Journal    
DOI: 10.1016/j.rinim.2013.10.004     Document Type: Article

References (39)

1. Andre I., Persson J., Blom A.M., Nilsson H., Drakenberg T., Lindahl G., Linse S. Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP. Biochemistry 2006, 45:4559-4568.
2. Blom A.M., Villoutreix B.O., Dahlback B. Functions of human complement inhibitor C4b-binding protein in relation to its structure. Arch immunol ther exp 2004, 52:83-95.
3. Calhoun J.H., Manring M.M., Shirtliff M. Osteomyelitis of the long bones. Semin Plast Surg 2009, 23:59-72.
4. Cunnion K.M., Hair P.S., Buescher E.S. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I. Infect Immun 2004, 72:2858-2863.
5. Cunnion K.M., Lee J.C., Frank M.M. Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun 2001, 69:6796-6803.
6. Daha M.R., van Es L.A. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein. J Immunol 1980, 125:2051-2054.
7. Deresinski S., Herrera V. Immunotherapies for Staphylococcus aureus: current challenges and future prospects. Infect Control Hosp Epidemiol 2010, 31(Suppl. 1):S45-S47.
8. Dieudonne-Vatran A., Krentz S., Blom A.M., Meri S., Henriques-Normark B., Riesbeck K., Albiger B. Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J Immunol 2009, 182:7865-7877.
9. Dryden M.S. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009, 34(Suppl. 1):S2-S7.
10. Fernandez Falcon M.F., Echague C.G., Hair P.S., Nyalwidhe J.O., Cunnion K.M. Protease inhibitors decrease IgG shedding from Staphylococcus aureus, increasing complement activation and phagocytosis efficiency. J Med Microbiol 2011, 60:1415-1422.
11. Fey P.D., Endres J.L., Yajjala V.K., Widhelm T.J., Boissy R.J., Bose J.L., Bayles K.W. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 2013, 4:e00537-12.
12. Fry D.E., Barie P.S. The changing face of Staphylococcus aureus: a continuing surgical challenge. Surg Infect 2011, 12:191-203.
13. Fujita T., Gigli I., Nussenzweig V. Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J Exp Med 1978, 148:1044-1051.
14. Gigli I., Fujita T., Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc Natl Acad Sci USA 1979, 76:6596-6600.
15. Goujon M., McWilliam H., Li W., Valentin F., Squizzato S., Paern J., Lopez R. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res 2010, 38:W695-9.
16. Gould I.M., Reilly J., Bunyan D., Walker A. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control. Clin Microbiol Infect 2010, 16:1721-1728.
17. Hair P.S., Echague C.G., Rohn R.D., Krishna N.K., Nyalwidhe J.O., Cunnion K.M. Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus. J Transl Med 2012, 10:35.
18. Hair P.S., Wagner S.M., Friederich P.T., Drake R.R., Nyalwidhe J.O., Cunnion K.M. Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization. Mol Immunol 2012, 50:253-261.
19. Hair P.S., Ward M.D., Semmes O.J., Foster T.J., Cunnion K.M. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis 2008, 198:125-133.
20. Jarva H., Ram S., Vogel U., Blom A.M., Meri S. Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J Immunol 2005, 174:6299-6307.
21. Jenkins H.T., Mark L., Ball G., Persson J., Lindahl G., Uhrin D., Blom A.M., Barlow P.N. Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factor. J Biol Chem 2006, 281:3690-3697.
22. Kask L., Villoutreix B.O., Steen M., Ramesh B., Dahlback B., Blom A.M. Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H. Protein Sci: Publ Protein Soc 2004, 13:1356-1364.
23. Kim H.K., Thammavongsa V., Schneewind O., Missiakas D. Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr Opin Microbiol 2012, 15:92-99.
24. Lambris J.D., Sahu A., Wetsel R.A. The chemistry and biology of C3, C4, and C5 1998, 83-118. Marcel Dekker, New York.
25. McCrea K.W., Hartford O., Davis S., Eidhin D.N., Lina G., Speziale P., Foster T.J., Hook M. The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology (Read, Engl) 2000, 146(Pt 7):1535-1546.
26. O'Brien L., Kerrigan G., Kaw S.W., Hogan M., Penades J., Litt D., Fitzgerald D.J., Foster T.J., Cox D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 2002, 44:1033-1044.
27. O'Connell D.P., Nanavaty T., McDevitt D., Gurusiddappa S., Hook M., Foster T.J. The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site. J Biol Chem 1998, 273:6821-6829.
28. Peacock S.J., Moore C.E., Justice A., Kantzanou M., Story L., Mackie K., O'Neill G., Day N.P. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun 2002, 70:4987-4996.
29. Perez-Roth E., Alcoba-Florez J., Lopez-Aguilar C., Gutierrez-Gonzalez I., Rivero-Perez B., Mendez-Alvarez S. Familial furunculosis associated with community-acquired leukocidin-positive methicillin-susceptible Staphylococcus aureus ST152. J Clin Microbiol 2010, 48:329-332.
30. Pietikainen J., Meri T., Blom A.M., Meri S. Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol Immunol 2010, 47:1299-1305.
31. Sabat A., Melles D.C., Martirosian G., Grundmann H., van Belkum A., Hryniewicz W. Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. J Clin Microbiol 2006, 44:1135-1138.
32. Sharp J.A., Echague C.G., Hair P.S., Ward M.D., Nyalwidhe J.O., Geoghegan J.A., Foster T.J., Cunnion K.M. Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic. PLoS ONE 2012, 7:e38407.
33. Spellberg B., Daum R. A new view on development of a Staphylococcus aureus vaccine: insights from mice and men. Hum Vaccines 2010, 6.
34. Stranger-Jones Y.K., Bae T., Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad SciUSA 2006, 103:16942-16947.
35. Tung H., Guss B., Hellman U., Persson L., Rubin K., Ryden C. A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J 2000, 345(Pt 3):611-619.
36. Vazquez V., Liang X., Horndahl J.K., Ganesh V.K., Smeds E., Foster T.J., Hook M. Fibrinogen is a ligand for the Staphylococcus aureus microbial surface components recognizing adhesive matrix molecules (MSCRAMM) bone sialoprotein-binding protein (Bbp). J Biol Chem 2012, 286:29797-29805.
37. Vytvytska O., Nagy E., Bluggel M., Meyer H.E., Kurzbauer R., Huber L.A., Klade C.S. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2002, 2:580-590.
38. Yang L., Nyalwidhe J.O., Guo S., Drake R.R., Semmes O.J. Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol Cell Proteomics 2011, 10. M110 007294.
39. Young T.P., Maas L., Thorp A.W., Brown L. Etiology of septic arthritis in children: an update for the new millennium. Am J Emerg Med 2011, 29:899-902.